Analysts Expect Alcentra Capital Corp (ABDC) Will Announce Quarterly Sales of $6.61 Million

Analysts forecast that Alcentra Capital Corp (NASDAQ:ABDC) will report $6.61 million in sales for the current fiscal quarter, according to Zacks. Four analysts have issued estimates for Alcentra Capital’s earnings. The highest sales estimate is $6.77 million and the lowest is $6.41 million. Alcentra Capital posted sales of $7.61 million in the same quarter last year, which would indicate a negative year-over-year growth rate of 13.1%. The firm is scheduled to issue its next earnings report on Monday, November 5th.

According to Zacks, analysts expect that Alcentra Capital will report full-year sales of $28.68 million for the current fiscal year, with estimates ranging from $28.34 million to $29.01 million. For the next financial year, analysts expect that the company will post sales of $26.94 million, with estimates ranging from $25.00 million to $28.62 million. Zacks’ sales averages are a mean average based on a survey of research firms that follow Alcentra Capital.

Alcentra Capital (NASDAQ:ABDC) last posted its quarterly earnings data on Monday, August 6th. The asset manager reported $0.25 EPS for the quarter, beating analysts’ consensus estimates of $0.20 by $0.05. Alcentra Capital had a positive return on equity of 10.10% and a negative net margin of 43.78%. The company had revenue of $7.25 million during the quarter, compared to analysts’ expectations of $6.82 million.

Separately, ValuEngine lowered Alcentra Capital from a “hold” rating to a “sell” rating in a research report on Thursday, August 2nd. Two research analysts have rated the stock with a sell rating and three have issued a hold rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $7.00.

NASDAQ:ABDC traded up $0.07 during trading hours on Thursday, reaching $5.82. 67,019 shares of the stock were exchanged, compared to its average volume of 65,103. Alcentra Capital has a twelve month low of $5.58 and a twelve month high of $9.01. The stock has a market capitalization of $78.74 million, a price-to-earnings ratio of 5.11 and a beta of 0.59.

Several institutional investors have recently bought and sold shares of ABDC. Salzhauer Michael increased its position in shares of Alcentra Capital by 100.8% during the second quarter. Salzhauer Michael now owns 247,178 shares of the asset manager’s stock worth $910,000 after acquiring an additional 124,057 shares during the period. Bank of New York Mellon Corp increased its position in shares of Alcentra Capital by 17.6% during the second quarter. Bank of New York Mellon Corp now owns 629,022 shares of the asset manager’s stock worth $4,019,000 after acquiring an additional 94,111 shares during the period. Finally, Belpointe Asset Management LLC purchased a new position in Alcentra Capital in the second quarter valued at $107,000. 33.59% of the stock is currently owned by institutional investors and hedge funds.

About Alcentra Capital

Alcentra Capital Corporation is a business development company specializing in investments in lower middle-market companies. The fund seeks to invest in healthcare, business services, defense, government services, telecom and technology, media, infrastructure maintenance and logistics, and oil and gas services sector.

See Also: Institutional Investors

Get a free copy of the Zacks research report on Alcentra Capital (ABDC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Alcentra Capital (NASDAQ:ABDC)

Receive News & Ratings for Alcentra Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply